Notifications

Home

Stocks
- Stock Screener
- Market Movers
- Insider Trades
- Upcoming Earnings
- Upcoming Dividends
Options
- Unusual Options Activity
- Implied Volatility Rank
- Volatility %Change
News
Upcoming IPOs

Vivos Therapeutics Inc (VVOS)

$0.16 -0.01 (-7.27%)

Overview
Financial
Short Interest
Institutional Holdings
Dividends
Charts

Market Cap	2.27M
Revenue (ttm)	17.44M
Net Income (ttm)	-21.17M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-121.39%
Debt to Equity Ratio	-2.04

Volume	1,668,000
Avg Vol	14,281,007
Day's Range	N/A - N/A
Shares Out	13.90M
Stochastic %K	20%
Beta	6.04
Analysts	Sell
Price Target	$2.12

Company Profile

Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test...

Industry: Medical Devices

Sector: Healthcare

Phone: 866 908 4867

Website: www.vivos.com

Address:

7921 Southpark Plaza, Suite 210, Littleton, United States

johh22 Sep. 19 at 10:25 PM

$VVOS H SCUMBAG ACInvestorblog was pumping this and PSQH and they are both down 90 pct plus . I hate that cocky pos . I would love to beat the fuck out of that scumbag. I wish he were man enough to sign a release to not press charges . I hate that scumbag pos .

0 · Reply

Giovannirs3 Sep. 18 at 8:09 PM

$VVOS 🤗🤡

0 · Reply

Giovannirs3 Sep. 18 at 8:08 PM

$VVOS 🤡

0 · Reply

Giovannirs3 Sep. 18 at 8:06 PM

$VVOS 🤡

0 · Reply

Giovannirs3 Sep. 18 at 5:28 PM

$VVOS 😁

0 · Reply

Giovannirs3 Sep. 18 at 4:48 PM

$VVOS 👎🤡

0 · Reply

Giovannirs3 Sep. 18 at 2:47 PM

$VVOS ➖️💯😁👆🔚

0 · Reply

Giovannirs3 Sep. 18 at 2:47 PM

$VVOS ➖️💯😁

0 · Reply

Giovannirs3 Sep. 18 at 1:00 PM

$VVOS ➖️💯😁🤣

0 · Reply

Giovannirs3 Sep. 18 at 7:22 AM

$VVOS 😁😁😁🤣🤣🤣🤡🤡🤡

0 · Reply

Vivos Therapeutics and South Palm Cardiovascular Associates Sign Definitive Agreements to Launch Regional Sleep Testing and Treatment Center

Vivos Therapeutics reports new patient referrals at Nevada Sleep & Airway

2026-08-25T12:56:23.000Z - 26 days ago

Vivos Therapeutics Opens New Sleep Testing and Treatment Facility in Nevada to Meet Rapidly Growing Patient Demand for Sleep Apnea Testing and Treatment

Vivos Therapeutics Earnings Call Transcript: Q2 2026

Aug 14, 2026, 5:00 PM EDT - 5 weeks ago

Vivos Therapeutics Expands Greenway Health Partnership to Deploy AI-Enabled Platform Across All Clinical and Revenue Operations

2026-08-05T14:01:57.000Z - 6 weeks ago

Vivos Therapeutics issued new U.S. patent for Vivos CARE devices

Aug 5, 2026, 8:30 AM EDT - 6 weeks ago

Vivos Therapeutics Announces Issuance of New US Patent Broadening Protection for Its Vivos CARE Oral Medical Device Technology

Vivos Therapeutics price target lowered to 75c from $1.75 at Alliance Global

2026-07-08T18:10:16.000Z - 2 months ago

Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity

Vivos Therapeutics intends to file registration statement for rights offering

2026-06-11T12:55:08.000Z - 3 months ago

Vivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea and Insomnia Diagnosis and Treatment to Cardiovascular Patients

Jun 9, 2026, 11:30 AM EDT - 3 months ago

Vivos Therapeutics Transcript: WTR Insights Conference: Powered by The Small Cap Showcase

Jun 8, 2026, 1:39 PM EDT - 3 months ago

Vivos Therapeutics To Participate in the Small Cap Showcase & WTR Insights on June 9, 2026

Jun 5, 2026, 8:45 AM EDT - 3 months ago

Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq Listing

Vivos Therapeutics reports Q1 EPS (52c), consensus (45c)

2026-05-20T20:22:09.000Z - 4 months ago

Vivos Therapeutics Reports that Supported Professional Practices Have Achieved 'In-Network' Status Across Multiple Commercial Health Insurers and Medicare in Key Nevada Market

Vivos Therapeutics’ oral medical devices proven to enhance airways

2026-03-17T13:00:18.000Z - 6 months ago

Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth's Groundbreaking FDA-Cleared Allergy and Sleep Technologies

Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds

Jan 20, 2026, 5:31 PM EST - 8 months ago

Vivos Therapeutics Releases Additional Clinical Data Showing Marked Improvement in Pediatric ADHD from Use of Vivos DNA Device

Vivos Therapeutics Proxy statement: Proxy Filing

Sep 29, 2025, 8:00 AM EDT - 11 months ago

New Clinical Trial Data Published Showing Positive Results from Use of Vivos Technology to Treat Obstructive Sleep Apnea in Children

Vivos Therapeutics Earnings Call Transcript: Q1 2025

May 15, 2025, 5:00 PM EDT - 1 year ago

Vivos Therapeutics Granted CPT® Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical Association

Oct 7, 2024, 8:00 AM EDT - 1 year ago

Vivos Therapeutics Proxy statement: Proxy Filing

Sep 18, 2024, 7:00 AM EDT - 2 years ago

Vivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea and Snoring

Vivos Therapeutics Earnings Call Transcript: Q2 2024

Aug 14, 2024, 5:00 PM EDT - 2 years ago

Vivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot of its New Provider-Based Marketing and Distribution Model

Jun 12, 2024, 7:30 AM EDT - 2 years ago

Vivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution Alliance

Vivos Therapeutics Earnings Call Transcript: Q1 2024

May 14, 2024, 5:00 PM EDT - 2 years ago

Giovannirs3 Sep. 18 at 8:09 PM

$VVOS 🤗🤡

0 · Reply

Giovannirs3 Sep. 18 at 8:08 PM

$VVOS 🤡

0 · Reply

Giovannirs3 Sep. 18 at 8:06 PM

$VVOS 🤡

0 · Reply

Giovannirs3 Sep. 18 at 5:28 PM

$VVOS 😁

0 · Reply

Giovannirs3 Sep. 18 at 4:48 PM

$VVOS 👎🤡

0 · Reply

Giovannirs3 Sep. 18 at 2:47 PM

$VVOS ➖️💯😁👆🔚

0 · Reply

Giovannirs3 Sep. 18 at 2:47 PM

$VVOS ➖️💯😁

0 · Reply

Giovannirs3 Sep. 18 at 1:00 PM

$VVOS ➖️💯😁🤣

0 · Reply

Giovannirs3 Sep. 18 at 7:22 AM

$VVOS 😁😁😁🤣🤣🤣🤡🤡🤡

0 · Reply

Giovannirs3 Sep. 18 at 7:10 AM

$VVOS 🤡🤡🤡🤡🤡

0 · Reply

NDSUBISON8 Sep. 18 at 2:40 AM

$VVOS up 10% why isn't there any chatter here??

4 · Reply

Giovannirs3 Sep. 17 at 8:13 PM

$VVOS 👍🔚➖️💯%%

0 · Reply

NDSUBISON8 Sep. 17 at 7:45 PM

$VVOS run to .25

0 · Reply

Giovannirs3 Sep. 17 at 6:38 PM

$VVOS 🤡🔚

0 · Reply

Giovannirs3 Sep. 17 at 4:51 PM

$VVOS 👍

0 · Reply

Tradingistheway Sep. 17 at 4:43 PM

$VVOS let’s run

0 · Reply

Giovannirs3 Sep. 17 at 8:59 AM

$VVOS 🌞

0 · Reply

billsmall Sep. 16 at 10:17 PM

$VVOS Oh she going to run, load up!!! NOT!!!! (Please don't listen to this you will lose it all) Remove Huntsman and hire a real marketing team. Now before it's all gone!

0 · Reply

Giovannirs3 Sep. 16 at 8:01 PM

$VVOS 👆🌞

0 · Reply

Giovannirs3 Sep. 16 at 7:48 PM

$VVOS 🔚

0 · Reply

NDSUBISON8 Sep. 16 at 7:38 PM

$VVOS i bought more lets ride b.tches

0 · Reply

1.0.0